[HTML][HTML] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
D Gordon, G Jang, M Bouhaddou, J Xu, K Obernier… - 2020 - agris.fao.org
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Food and
Agriculture Organization of the United Nations Discover About FAO News Multimedia Main …
Agriculture Organization of the United Nations Discover About FAO News Multimedia Main …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu… - …, 2020 - research-collection.ethz.ch
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu… - Nature, 2020 - econpapers.repec.org
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu… - Nature, 2020 - scholars.uthscsa.edu
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier… - Nature, 2020 - cdr.lib.unc.edu
The novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease,
has infected over 2.3 million people, killed over 160,000, and caused worldwide social and …
has infected over 2.3 million people, killed over 160,000, and caused worldwide social and …
[HTML][HTML] A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier… - Nature, 2020 - ncbi.nlm.nih.gov
The novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease,
has infected over 2.3 million people, killed over 160,000, and caused worldwide social and …
has infected over 2.3 million people, killed over 160,000, and caused worldwide social and …
[引用][C] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier… - Nature, 2020 - cir.nii.ac.jp
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier… - Nature, 2020 - go.gale.com
SARS-CoV-2 is an enveloped, positive-sense, single-stranded RNA betacoronavirus of the
family Coronaviridae 3, 4. Coronaviruses that infect humans historically included several …
family Coronaviridae 3, 4. Coronaviruses that infect humans historically included several …
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
DE Gordon, GM Jang, M Bouhaddou, J Xu… - …, 2020 - ui.adsabs.harvard.edu
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …
(SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has …